EPRX EUPRAXIA PHARMACEUTICALS INC: institutional ownership and insider trading
67 funds reported holding $164M of EUPRAXIA PHARMACEUTICALS INC in their latest 13F filings; in Q2 2026 funds net bought $8.27M, with 16 new positions and 6 funds selling out.
Famous investors holding EPRX
- Ken Griffin (Citadel Advisors): $3.32M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $2.92M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.46M, 0.0% of the portfolio
Largest institutional holders of EPRX
- Beutel, Goodman & Co Ltd. — $23.8M
- Affinity Asset Advisors, LLC — $10.9M
- BALYASNY ASSET MANAGEMENT L.P. — $8.92M
- Vivo Capital, LLC — $8.92M
- SCOTIA CAPITAL INC. — $8.78M
- PFM Health Sciences, LP — $8.00M
- GREAT POINT PARTNERS LLC — $7.93M
- Jupiter Topco LLC — $6.85M
- Rubric Capital Management LP — $5.73M
- Ikarian Capital, LLC — $5.35M
5%+ owners
- Joseph S. Freedman: 9.0% (Schedule 13D/A, filed Mar 16, 2026)
- Morgan C. Frank: 7.7% (Schedule 13G/A, filed May 12, 2026)